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Abstract
OBJECTIVE—To evaluate the effectiveness and cost of bidirectional short messaging service in 
increasing rates of vaccination and well child care (WCC) among adolescents.
METHODS—We included all adolescents needing a recommended adolescent vaccine (n = 4587) 
whose parents had a cell-phone number in 5 private and 2 safety-net pediatric practices. 
Adolescents were randomized to intervention (n = 2228) or control (n = 2359). Parents in the 
intervention group received up to 3 personalized short messaging services with response options 1 
(clinic will call to schedule), 2 (parent will call clinic), or STOP (no further short messaging 
service). Primary outcomes included completion of all needed services, WCC only, all needed 
vaccinations, any vaccination, and missed opportunity for vaccination.
RESULTS—Intervention patients were more likely to complete all needed services (risk ratio 
[RR] 1.31, 95% confidence interval [CI] 1.12–1.53), all needed vaccinations (RR 1.29, 95% CI 
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1.12–1.50), and any vaccination (RR 1.36, 95% CI 1.20–1.54). Seventy-five percent of control 
patients had a missed opportunity versus 69% of intervention (P = .002). There was not a 
significant difference for WCC visits. Responding that the clinic should call to schedule (“1”) was 
associated with the highest effect size for completion of all needed services (RR 1.89, 95% CI 
1.41–2.54). Net cost ranged from $855 to $3394 per practice.
CONCLUSIONS—Bidirectional short messaging service to parents was effective at improving 
rates for all adolescent vaccinations and for all needed services, especially among parents who 
responded they desired a call from the practice.
Childhood vaccination is commonly cited as one of the greatest public health achievements 
in history. However, for several vaccinations, and in certain populations, vaccination rates 
remain suboptimal. Among the interventions for increasing vaccination rates that have been 
studied, “reminder/recall” is considered one of the more effective.1 Reminders, meaning 
prompting a parent that a child is due for an upcoming vaccine, and recalls, meaning alerting 
a parent that a child is overdue, have traditionally been performed using mailed messages or 
telephone calls.2
Reminder/recall may be particularly useful for adolescents. Adolescents tend to visit 
medical providers less frequently than younger children, and are less likely to receive 
preventive visits.3 Also, several of the recommendations for adolescent vaccinations are less 
than a decade old, so parents may not be aware of these newer recommendations. One of the 
adolescent vaccines requires a 3-dose series, complicating delivery. Current 
recommendations for adolescent vaccination include a tetanus-diphtheria-acellular pertussis 
(Tdap) vaccine at age 11 to 12, a meningococcal conjugate vaccine (MCV) at age 11 to 12 
with a booster at age 16, the 3-dose human papillomavirus (HPV) vaccine series, to be 
started at age 11 to 12, and a yearly influenza vaccine.4 Adolescent vaccination rates lag 
well behind other childhood rates, particularly for HPV vaccine.5 Although traditional 
reminder/recall, using mail and telephone calls, has been shown to be effective in adolescent 
patients,6,7 it remains underused.8 A national survey showed that only 16% of pediatricians 
routinely use reminder/recall, primarily because traditional methods of reminder/recall are 
time-consuming or expensive.9
Short messaging service, better known as text messaging, has potential advantages over 
traditional reminder/recall methodologies. However, the use of text messaging for reminder/
recall remains understudied, particularly in private practice settings.10 Also, previous studies 
of reminder/recall, including text messaging, have primarily relied on unidirectional 
prompts, meaning that the recipient cannot respond. There is some evidence that 
encouraging a recipient to make a plan may serve as a behavioral prompt that may be more 
effective at accomplishing a desired health outcome than a simple reminder.11 Therefore, the 
objectives of this study were (1) to evaluate the effectiveness and cost of bidirectional text 
messaging in increasing rates for all adolescent vaccines and well child care (WCC), and (2) 
to compare results by type of response to the text message.
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METHODS
Study Setting
The study protocol was approved by the Colorado Multiple Institutional Review Board as an 
expedited protocol, not requiring consent. We conducted the study in 5 urban/suburban 
private pediatric practices and 2 safety-net practices in Colorado from September 2012 to 
August 2013. Practices in the greater Denver area were contacted by e-mail and/or telephone 
for interest in participation followed by meetings with interested practices to confirm 
participation. Practices were chosen purposefully based on their patient populations to 
represent a diverse cross section. Race/ethnicity was not routinely collected at the 5 private 
practices. In general, they are typical of the racial/ethnic breakdown of Colorado and accept 
between 10% and 35% Medicaid. The populations of the 2 safety-net practices, which were 
part of a larger system, were approximately 50% Hispanic, 30% non-Hispanic white, 10% 
African American, and 10% other, with 82% public insurance, 15% private insurance, and 
3% uninsured.
All study practices participate in the Colorado Immunization Information System (CIIS), 
which includes all immunizations administered at participating sites, which in Colorado 
includes most primary care practices, school-based health centers, local public health 
agencies, and some pharmacies. Data in CIIS undergo routine quality checks and standard 
data validation checks for all new interfaces.
Intervention Development
The intervention was developed collaboratively with the 7 practices in the study. Adolescent, 
parent, and provider input was solicited through a series of focus groups and key informant 
interviews. Based on the feedback from this process, a series of collaborative meetings were 
held with the intervention practices, during which the logistics of the intervention were 
developed.12
Study Design and Population
This was a randomized controlled trial with randomization at the patient level within each 
practice using random number generation (SAS 9.3; SAS Institute, Cary, NC). Providers 
were blinded to group allocation. The study population was a sample of adolescents aged 11 
to 17 years seen at their practice at least once in the preceding 2 years. Adolescents were 
eligible for the study if they needed ≥1 of the targeted adolescent vaccines (Tdap, MCV4, 
and HPV) or WCC, defined as no WCC in the previous year. In the case in which an 
adolescent had ≥1 siblings who also met inclusion criteria, only 1 adolescent from the 
household was randomly chosen to be in the study. Parents and adolescents were blinded to 
which child was chosen for study inclusion; therefore, eligible nonstudy siblings received 
the same intervention as the study adolescent without analysis of their data.
Data Sources
Administrative data from the practices’ electronic billing systems, including historical data, 
were merged with CIIS data, and these combined data were used to determine which 
adolescents were eligible. Parent cell-phone numbers were determined from administrative 
O’Leary et al. Page 3
Pediatrics. Author manuscript; available in PMC 2018 March 13.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
data by scanning electronic telephone fields for cell-phone numbers (SearchBug, Encinitas, 
CA).
Short Messaging Service Intervention
Parents of adolescents in the intervention group were sent a text message with the following 
script: “We show [first name] is due for a [vaccine OR checkup or vaccine and checkup]. 
REPLY 1 for us to call you to schedule, 2 if you will call us, or STOP to end messages 
[practice name and phone number].” Replies of STOP were removed from further messages. 
All other replies received the following automated response: “This is an automated response. 
For emergencies, call 911. If you replied 1, we’ll call you soon. For questions or to schedule, 
please call the office.” Parents who responded in any way were removed from further text 
messages. The study team tracked all responses. Lists of parents who responded 1 and 2 
were provided to the practices weekly. Practices agreed to call all parents who responded 1 
to schedule appointments. Appointment schedules were pulled from electronic practice 
schedules and tracked weekly. Any patient not already removed from future texts who had 
an upcoming appointment was removed from further text messages. Among those who did 
not respond, up to 3 more text messages were sent every 2 weeks, so that the last text 
message was sent approximately 6 weeks after the first. Text messages were sent using 
MessageMedia (San Francisco, CA).
Parents of patients in the usual care group received no reminders as part of the study, and 
none of the practices used any reminders during the study.
Analytic Methods
Primary outcomes were completion of (1) all needed immunizations and/or WCC, (2) WCC, 
(3) all immunizations, (4) any immunization, and (5) missed opportunities for immunization, 
defined as any visit to the practice during the study period in which a vaccination was 
needed but not given. Secondary outcomes included results by individual vaccine and by 
parental response to the text message. All outcomes were assessed 6 months after the last 
text message.
The primary analysis was intention-to-treat (ITT) in which all individuals were analyzed 
within the group to which they were randomized. Per-protocol analyses were limited to 
those intervention parents who received at least 1 of the text messages (delivery status 
provided by MessageMedia). Like the intervention group, the usual care group included only 
parents who had access to a cell-phone. Neither randomization nor analysis was stratified by 
gender. Comparisons between the ITT and usual care groups and baseline demographics 
were conducted to determine balance between the groups. Generalized linear random effects 
models were used to determine differences between the ITT and per protocol (PP) groups for 
primary and secondary outcomes. All models were adjusted as necessary for age, insurance, 
and potential random effects of clinic. Relative risks were generated by using a log link with 
a binomial distribution in the regression model.13
The cost analysis was conducted for the 5 private practices that participated in the study, 
from the practice’s perspective. The safety-net clinics were not included in the cost analysis 
because their scheduling processes were markedly different from the private practices and 
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therefore not comparable. The 4 cost activity areas related to the text messaging intervention 
were development of the text message, staff training, data management, and implementation. 
Practices’ ability to link data between clinical, scheduling, billing, and text messaging 
systems varied. Therefore, intervention costs were estimated by using 3 different 
hypothetical scenarios for each of the 5 clinics based on practice costs related to various data 
linkage capabilities: scenario 1: no electronic system linkage between clinical, scheduling, 
billing or text messaging and no cell-phone field in electronic data; scenario 2: system 
linkages between clinical, scheduling and billing but not text messaging and with a cell-
phone field; scenario 3: each of the 4 systems linked and cell-phone field. Cost data were 
derived by identifying staff involved with text message reminder/recall and estimating their 
time related to these activities during the start-up and implementation period (2 months). 
Therefore, the length of time for the cost analysis was a 3-month period including 
development, training, and implementation. The study team performed timed observations at 
each clinic of staff performing duties, such as answering questions regarding the text 
messages and scheduling appointments. Job titles of the relevant staff were linked to the job 
titles and relevant median wages from the Bureau of Labor Statistics for the State of 
Colorado 2012.14 Benefits were added and calculated as 30% of wages. Cost of vaccines 
was not included in the analysis. Summary costs per outcome were estimated for each of the 
3 scenarios.
RESULTS
Figure 1 shows the consolidated standards of reporting trials diagram showing the selection 
of the study population, which included 2228 parents randomized to intervention and 2359 
to control. Details of the study population are shown in Table 1. At baseline, there were no 
significant differences between intervention and control groups in terms of age or up-to-date 
status for any of the primary outcomes.
Eighty-four percent (1877/2228) of parents who were sent a text message received the 
message according to the carrier. Among those parents who were sent a text message, 30% 
(n = 662) responded by text message. The most frequent response was that the parent would 
like to receive a phone call from the clinic to schedule an appointment (1, 41%), followed by 
that the parent would call the clinic at a later time (2, 28%), followed by STOP, meaning end 
future messages (22%). Nine percent of parents responded in some other way (such as with 
a question). Most responses (65%) occurred with the first text message.
Primary outcomes for the ITT analysis are shown in Table 2. Intervention patients were 
more likely to complete all needed services, meaning all needed vaccinations and WCC (risk 
ratio [RR] 1.31, 95% confidence interval [CI] 1.12–1.53, number needed to treat [NNT] 35), 
complete all needed vaccinations (RR 1.29, P = .0006, NNT 32), and complete any 
vaccination (RR 1.35, P < .0001, NNT 19). Seventy-five percent of patients in the control 
group experienced a missed opportunity for vaccination compared with 69% in the 
intervention group (P = .002). Analyzed alone, there was not a significant difference 
between intervention and control groups for WCC.
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Also shown in Table 2 are results by parental response to the text messages. A response 
requesting a call from the clinic (1) resulted in the highest effect size. Adolescents whose 
parents replied STOP were less likely than the control group to receive the needed services, 
and this finding was significant for all study outcomes. Those who did not respond, which 
was most of the intervention population, still generally had favorable outcomes compared 
with controls.
With the exception of the MCV booster dose, there was a significant difference between 
intervention and control for all of the vaccine doses examined (Table 3). There was a 
significant difference for each HPV dose, with 16% of the intervention group who needed 
any dose receiving it compared with 12% among controls (P < .0001). However, most of the 
study population was missing their first dose of HPV vaccine, and although there was a 
significant difference, the overall effect on the first dose was small (11% vs 9%, P = .04). 
For patients for whom HPV was the only needed service (about half the study population), 
19% of the intervention group compared with 15% of the control group received at least 1 
dose of the vaccine (P = .002). In subgroup analyses for HPV series completion, no 
differences were found by practice type (private, public), age (11–12, 13–15, 16–17) or 
insurance type (private, public, no insurance).
Per-protocol analyses were performed for all study outcomes and were consistent with ITT 
analyses.
The practice costs for each of the 3 scenarios are summarized in Table 4. The greater the 
data linkage capability the fewer resources required for data management and quality and for 
conducting reminder/recall. Table 5 describes the cost per outcome for each of the 3 
scenarios. The average cost per clinic over the intervention period ranged from $855 to 
$3394 per practice and an average cost per child of $2.64 to $10.48. As a smaller percentage 
of children completed WCC than vaccinations, the cost per WCC visit was higher than any 
of the vaccination outcomes, ranging from $61.96 to $245.94.
DISCUSSION
This study among 5 private and 2 safety-net practices shows that bidirectional text 
messaging to parents was effective at improving rates for all adolescent vaccinations and for 
all needed services, even if the parent did not respond to the text message. In addition, those 
who responded that they desired a call from the practice achieved higher completion rates. 
The impact of the intervention was consistent with other methods of reminder/recall but 
overall was modest.2 Missed opportunities for vaccination were high in both intervention 
and control groups, emphasizing the need for providers to use every opportunity to 
vaccinate, particularly for adolescent patients.
Text messaging has been shown to be effective at increasing vaccination coverage in 
previous studies, including children and adolescents, pregnant women, and in an adult travel 
clinic.10,15–17 One study showed a lack of effectiveness for text messaging for increasing 
influenza vaccination coverage in a mostly African American population.18 What all of 
those studies have in common is that they were performed in clinics affiliated with academic 
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medical centers with predominantly low-income, urban populations. In the current study, we 
purposely sought out a broader range of practice types to better evaluate the effectiveness of 
text messaging in typical private practice and community health center settings.
It is not clear if the bidirectional nature of our intervention offered much advantage over a 
unidirectional text message. Parents who responded with an intention, though, were more 
likely to have their child vaccinated compared with those who did not respond. Bidirectional 
text messaging can be considered a form of “implementation intention,” meaning asking a 
person to develop a plan. Psychology research has shown that simply prompting people to 
develop a plan for a desired action can increase the likelihood of success.19–23 Bidirectional 
text messaging offers a prompt to form an implementation intention which may “nudge” a 
parent in the direction of the desired behavior,24 which in this case was to take their child in 
for a needed vaccination or well-child visit. One previous study showed a small increase in 
uptake of influenza vaccine by using a similar psychological prompt.11 Such low-cost 
psychological interventions to change behavior deserve further examination in the field of 
immunizations.
This study must be considered in the context of low uptake of HPV vaccine.25 For 
approximately half the study population, a missing dose of HPV vaccine was the only 
needed service, and approximately three-fourths of the study population was missing the 
first dose. For some of these adolescents, parents may have refused HPV vaccine at a 
previous visit and therefore a text message might not be expected to have much effect. 
Nonetheless, with low national rates for initiation and completion of the HPV vaccine series, 
our finding of improvement in uptake of HPV vaccine with a simple text message has 
important implications. Because there are so many adolescents nationally missing HPV 
vaccine, text messaging could offer a needed boost to low rates at a relatively low cost. 
However, strategies to address parental and provider attitudes are needed to substantially 
affect HPV vaccination coverage levels.
Although this study demonstrates that text messaging is effective at increasing vaccination 
rates in adolescents, it is unknown if practices will use this technology. Few providers use 
reminder/recall for vaccination presently.8,9 There are several reasons why one might expect 
practices to adopt text messaging over traditional reminder/recall modalities. Text messaging 
for reminder/recall has the advantage of scalability. It has the potential to be less expensive 
than mail or personal phone calls, and certainly can be automated much more easily. It also 
offers the potential advantage to parents of being more efficient than a telephone call, 
whether automated or personal, as parents can quickly read the message rather than listen to 
a telephone reminder that lasts 30 seconds or more. Further, text reminders often remain on 
the phone, so there is no need for a parent to write down the reminder as there would be with 
a telephone call. As technology advances and interfaces improve between electronic health 
records (EHRs) and state immunization information systems, identifying which patients are 
due or overdue for vaccinations or WCC should become easier for practices to do, and 
therefore text messaging for such reminders could be automated. Text messaging also could 
be used by state or local public health departments through local or regional immunization 
information systems, as centralized reminder/recall has been shown to be more effective 
than reminder/recall performed by individual practices.8
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Similar to a recent cost-effectiveness study of postal and auto-dialer reminder/recall for 
adolescent vaccines,6 we chose to reflect the cost of text message reminder/recall from the 
perspective of pediatric practices. However, in contrast to that study, we specifically chose 
not to address revenue in our cost analysis, as cost and payment for vaccines varies greatly 
across states and practices.26,27 If we compare only costs between the 2 studies, they were 
similar, at least for our scenarios 2 and 3 ($1087–$1349 in that study versus $855–$1658). 
Scenario 1 reflects a “worst-case scenario,” for practices in early stages of EHR adoption or 
with rudimentary systems. In such cases, use of text messaging would likely be cost 
prohibitive. Scenario 2 reflects the situation for most practices in this study. The technology 
exists to use text message reminders in a more automated fashion, though, as reflected in 
scenario 3, and this analysis may provide a more accurate prediction of what practices in 
later stages of EHR adoption would spend to use text messages for reminder/recall. Some of 
our cost was related to the bidirectional nature of our intervention, an optional feature, and 
practices should consider this in interpreting these data.
This study has strengths and limitations. It is the first study performed in a mixture of public 
and private settings not affiliated with an academic medical center, and is therefore 
potentially more generalizable than previous studies. We also had a large sample size. 
However, it was all in 1 state in urban or suburban areas. We also were not able to fully 
explore the impact of bidirectionality, as we did not directly compare unidirectional with 
bidirectional text messaging. Also, the text messages were delivered only in English, which 
could have blunted the impact of the intervention in non–English speaking families. Finally, 
our study team did much of the work of data collection and organizing and sending the text 
messages, which limits assessments of sustainability.
CONCLUSIONS
Providers in diverse settings should consider text messaging as a viable method of reminder/
recall in their adolescent patient populations, and the use of bidirectionality as a prompt for 
an intended action deserves further study. Although the cost of text message reminder/recall 
may be similar to more traditional reminder/recall modalities in the current environment, 
text messaging, because of its potential for automation and scalability, may represent the 
future of reminder/recall.
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WHAT’S KNOWN ON THIS SUBJECT
Adolescent vaccination rates lag behind other childhood vaccines. Text messaging to 
improve uptake of adolescent vaccines has been shown to be effective in academic 
centers but has not been studied in other settings.
WHAT THIS STUDY ADDS
This study, done in 5 private and 2 safety-net practices, used a bidirectional text message 
as a behavioral prompt and showed text messaging was effective at increasing uptake of 
all adolescent vaccines. Costs were similar to other reminder/recall methods.
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FIGURE 1. 
Consolidated standards of reporting trials diagram of text messaging intervention.
O’Leary et al. Page 12
Pediatrics. Author manuscript; available in PMC 2018 March 13.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
O’Leary et al. Page 13
TABLE 1
Baseline Characteristics of Study Population, Intervention Compared With Usual Care, With Proportion of 
Population Needing Adolescent Vaccinations or WCC
Measure Intervention, n = 2228 Usual Care, n = 2359a P b
Gender, % boys 52.4 54.6 .14
Age, average y 14.1 14.1 .65
Need WCC, % 25.3 23.7 .21
Tdap, % 21.6 20.9 .59
MCV4c, % 43.2 42.0 .42
MCV4 vaccination, % 31.1 29.9 .36
MCV4 booster, % 12.1 12.1 .96
HPV seriesd, % 94.4 94.4 .92
HPV dose 1, % 70.6 71.8 .38
HPV dose 2, % 16.0 15.6 .66
HPV dose 3, % 7.9 7.0 .29
Need HPV onlye, % 50.1 52.2 .18
a
For WCC and vaccinations, the percentages represent the proportion of the population in need of the specified service; total numbers are different 
between intervention and usual care because of the exclusion of eligible siblings, with only 1 sibling randomly selected for participation in the 
study, with siblings reallocated to the same arm.
bStudent’s t test (age) and χ2.
c
Includes patients needing either the initial MCV4 vaccine or the MCV4 booster at baseline.
d
Includes patients needing the HPV dose 1, HPV dose 2, or HPV dose 3 at baseline.
e
Includes only patients needing 1 of the HPV doses (ie, did not need WCC, Tdap, or MCV4).
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TABLE 3
Secondary Study Outcomes (by Vaccine Type), ITT Analysis
Measure Intervention, % (n) Usual Care, % (n) RR (95% CI)
Tdap 13.5 (65/480) 9.7 (48/493) 1.42 (1.00–2.01)
MCV4a 17.0 (164/962) 12.2 (121/991) 1.40 (1.12–1.74)
MCV4 vaccine 17.6 (122/693) 12.5 (88/705) 1.42 (1.10–1.83)
MCV4 booster 15.6 (42/269) 11.5 (33/286) 1.41 (0.93–2.14)
HPV seriesb 16.6 (349/2104) 12.6 (280/2226) 1.35 (1.17–1.56)
HPV dose 1 10.9 (171/1572) 9.0 (152/1693) 1.24 (1.01–1.52)
HPV dose 2 33.1 (118/357) 24.0 (88/367) 1.38 (1.09–1.75)
HPV Dose 3 34.3 (60/175) 24.1 (40/166) 1.42 (1.01–2.00)
HPV onlyc 19.4 (204/1054) 14.8 (172/1161) 1.31 (1.09–1.57)
a
Denominator includes patients needing either the initial MCV4 vaccine or the MCV4 booster at baseline. Numerator includes patients completing 
either the vaccine or booster.
b
Denominator includes patients needing the HPV dose 1, HPV dose 2, or HPV dose 3 at baseline. Numerator includes patients completing at least 
one dose of HPV.
c
Includes only patients needing 1 of the HPV doses (ie, did not need WCC, Tdap, or MCV4).
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TABLE 4
Cost of Text Message Reminder Recall for 5 Practices
Scenario 1a Scenario 2 Scenario 3
Reminder recall development 1575 1575 1575
Training 330 330 330
Data management/quality 11 213 2010 370
Reminder/recall 4377 4377 2000
Total 16 970 8292 4275
Costs represent the total cost ($) for development of the text message, staff training, data management, and implementation for the 5 private 
practices in the study over a 3-month period.
aScenario 1: no electronic system linkage between clinical, scheduling, billing, or text messaging and no cell-phone field in electronic data; 
scenario 2: system linkages between clinical, scheduling, and billing but not text messaging and with a cell-phone field; scenario 3: each of the 4 
systems linked and cell-phone field.
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TABLE 5
Cost Effectiveness of Text Message Reminder Recall
n Scenario 1a Scenario 2 Scenario 3
Cost/n Cost/n Cost/n
Cost per clinic 5 3394.00 1658.40 855.00
Cost per child 1620 10.48 5.12 2.64
Cost per all needed 173 98.09 47.93 24.71
Cost per well-child visit 69 245.94 120.17 61.96
Cost per all vaccinations 197 86.14 42.09 21.70
Cost per any vaccination 301 56.38 27.55 14.20
Costs (in $) are based on the number of children who needed each specified service.
aScenario 1: no electronic system linkage between clinical, scheduling, billing, or text messaging and no cell-phone field in electronic data; 
scenario 2: system linkages between clinical, scheduling, and billing but not text messaging and with a cell-phone field; scenario 3: each of the 4 
systems linked and cell-phone field.
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